Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Capdevila

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Targeted Oncology|November 10, 2009
Molecular targeted therapies in the treatment of gastroenteropancreatic neuroendocrine tumorsJaume Capdevila, Ramon Salazar
Cancer Discovery|May 16, 2012
A shining light in the darkness for the treatment of pancreatic neuroendocrine tumorsJaume Capdevila, Josep Tabernero
Biologics : Targets & Therapy|April 22, 2014
Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinibNeda Stjepanovic, Jaume Capdevila
Immunotherapy|July 20, 2010
New trends in epidermal growth factor receptor-directed monoclonal antibodiesBen Markman, Jaume Capdevila, Elena Elez, et al.
Current Treatment Options in Oncology|March 31, 2021
Drug Development in Neuroendocrine Tumors: What Is on the Horizon?Alejandro Garcia-Alvarez, Jorge Hernando Cubero, Jaume Capdevila
Current Oncology Reports|February 16, 2022
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?Alejandro Garcia-Alvarez, Jorge Hernando Cubero, Jaume Capdevila
Critical Reviews in Oncology/Hematology|June 14, 2014
What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?Jaume Capdevila, Alfredo Carrato, Josep Tabernero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2006
Disseminated retroperitoneal choriocarcinoma with open fistula to intestine. "Restitutio ad integrum" with chemotherapy aloneJaume Capdevila, Pablo Maroto, Sergio Sainz, et al.
Current Medicinal Chemistry|February 15, 2020
Clinical and Translational Challenges in Thyroid CancerJorge Hernando, Javier Ros, Alvaro Arroyo, et al.
Expert Opinion on Emerging Drugs|September 1, 2016
Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancerIgnacio Matos, Elena Elez, Jaume Capdevila, et al.
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Targeted Oncology|November 10, 2009
Molecular targeted therapies in the treatment of gastroenteropancreatic neuroendocrine tumorsJaume Capdevila, Ramon Salazar
Cancer Discovery|May 16, 2012
A shining light in the darkness for the treatment of pancreatic neuroendocrine tumorsJaume Capdevila, Josep Tabernero
Biologics : Targets & Therapy|April 22, 2014
Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinibNeda Stjepanovic, Jaume Capdevila
Immunotherapy|July 20, 2010
New trends in epidermal growth factor receptor-directed monoclonal antibodiesBen Markman, Jaume Capdevila, Elena Elez, et al.
Current Treatment Options in Oncology|March 31, 2021
Drug Development in Neuroendocrine Tumors: What Is on the Horizon?Alejandro Garcia-Alvarez, Jorge Hernando Cubero, Jaume Capdevila
Current Oncology Reports|February 16, 2022
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?Alejandro Garcia-Alvarez, Jorge Hernando Cubero, Jaume Capdevila
Critical Reviews in Oncology/Hematology|June 14, 2014
What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?Jaume Capdevila, Alfredo Carrato, Josep Tabernero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2006
Disseminated retroperitoneal choriocarcinoma with open fistula to intestine. "Restitutio ad integrum" with chemotherapy aloneJaume Capdevila, Pablo Maroto, Sergio Sainz, et al.
Current Medicinal Chemistry|February 15, 2020
Clinical and Translational Challenges in Thyroid CancerJorge Hernando, Javier Ros, Alvaro Arroyo, et al.
Expert Opinion on Emerging Drugs|September 1, 2016
Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancerIgnacio Matos, Elena Elez, Jaume Capdevila, et al.
Pageof 20